发明名称 METHODS AND COMPOSITIONS FOR INCREASING A T-EFFECTOR CELL TO REGULATORY T CELL RATIO
摘要 The present invention is directed to methods for increasing T-cell effector cell to regulatory T cell ratio. The invention is further directed to methods of treating, protecting against, and inducing an immune response against a tumor, comprising the step of administering to a subject a recombinant Listeria strain, comprising a fusion peptide that comprises an LLO fragment and tumor-associated antigen.
申请公布号 US2017080064(A1) 申请公布日期 2017.03.23
申请号 US201515123468 申请日期 2015.03.05
申请人 ADVAXIS, INS. ;NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMANS SERVICES (DHHS), U.S. GOVERNMEN 发明人 Petit Robert;Wallecha Anu;Chen Zhisong;Berzofsky Jay A;Khleif Samir
分类号 A61K39/00 主分类号 A61K39/00
代理机构 代理人
主权项 1. A method of eliciting an anti-tumor T cell response in a subject having a tumor or cancer, comprising the step of administering to said subject a recombinant Listeria strain comprising a recombinant nucleic acid, said nucleic acid molecule comprising a first open reading frame encoding a recombinant polypeptide and a second open reading frame second open reading frame encoding a metabolic, wherein said recombinant polypeptide comprises a truncated LLO protein fused to a heterologous antigen or fragment thereof, wherein said Listeria comprises a mutation in the endogenous alanine racemase gene (dal), D-amino acid transferase gene (dat), and actA genes, and wherein said T-cell response comprises increasing a ratio of T effector cells to regulatory T cells (Tregs), thereby eliciting an anti-tumor T cell response in said subject.
地址 East Princeton NJ US